Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
Patient Education Webcasts
Insight into Chronic Myeloid Leukemia (CML)
NexImmune Completes Dosing of First Cohort in Phase 1/2 Clinical Trial of NEXI-001 in Relapsed AML
GAITHERSBURG, MD - September 23, 2020 – NexImmune, a clinical-stage biotechnology company developing unique non-genetically-engineered T cell immunoth…
Greater Connecticut Board of Trustees
Meet The Leukemia & Lymphoma Society's Greater Connecticut Board of Trustees
Westchester Fairfield Board of Trustees
Meet The Leukemia & Lymphoma Society's Westchester Fairfield Board of Trustees
Magrolimab Receives FDA Breakthrough Therapy Designation for Treatment of MDS
September 15, 2020 - FOSTER CITY, Calif. - Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has g…
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.
